Literature DB >> 23834230

Synthesis and structure-activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor.

Anuj Khandelwal1, Jessica A Hall, Brian S J Blagg.   

Abstract

Epigallocatechin-3-gallate (EGCG), the principal polyphenol isolated from green tea, was recently shown to inhibit Hsp90; however, structure-activity relationships for this natural product have not yet been produced. Herein, we report the synthesis and biological evaluation of EGCG analogues to establish structure-activity relationships between EGCG and Hsp90. All four rings as well as the linker connecting the C- and the D-rings were systematically investigated, which led to the discovery of compounds that inhibit Hs90 and display improvement in efficacy over EGCG. Antiproliferative activity of all the analogues was determined against MCF-7 and SKBr3 cell lines and Hsp90 inhibitory activity of the four most potent analogues was further evaluated by Western blot analyses and degradation of Hsp90-dependent client proteins. The prenyl-substituted aryl ester of 3,5-dihydroxychroman-3-ol ring system was identified as a novel scaffold that exhibits Hsp90 inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23834230      PMCID: PMC4123816          DOI: 10.1021/jo401027r

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  39 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

Review 2.  Hsp90 as a target for drug development.

Authors:  Subhabrata Chaudhury; Timothy R Welch; Brian S J Blagg
Journal:  ChemMedChem       Date:  2006-12       Impact factor: 3.466

3.  Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.

Authors:  Shengmin Sang; Mao-Jung Lee; Zhe Hou; Chi-Tang Ho; Chung S Yang
Journal:  J Agric Food Chem       Date:  2005-11-30       Impact factor: 5.279

4.  Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors.

Authors:  Sheng Biao Wan; Kristin R Landis-Piwowar; Deborah J Kuhn; Di Chen; Q Ping Dou; Tak Hang Chan
Journal:  Bioorg Med Chem       Date:  2005-03-15       Impact factor: 3.641

5.  Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein.

Authors:  Christine M Palermo; Claire A Westlake; Thomas A Gasiewicz
Journal:  Biochemistry       Date:  2005-04-05       Impact factor: 3.162

6.  One-pot regio- and stereoselective cyclization of 1,2,n-triols.

Authors:  Tao Zheng; Radha S Narayan; Jennifer M Schomaker; Babak Borhan
Journal:  J Am Chem Soc       Date:  2005-05-18       Impact factor: 15.419

7.  Synthesis of the transfer-RNA nucleoside queuosine by using a chiral allyl azide intermediate.

Authors:  Florian Klepper; Eva-Maria Jahn; Volker Hickmann; Thomas Carell
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 8.  Hsp90: a novel target for the disruption of multiple signaling cascades.

Authors:  Stephanie C Bishop; Joseph A Burlison; Brian S J Blagg
Journal:  Curr Cancer Drug Targets       Date:  2007-06       Impact factor: 3.428

9.  (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor.

Authors:  Zhengyu Yin; Ellen C Henry; Thomas A Gasiewicz
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

10.  Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.

Authors:  Aslamuzzaman Kazi; Zhigang Wang; Naveen Kumar; Samuel C Falsetti; Tak-Hang Chan; Q Ping Dou
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

View more
  16 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

3.  Development of radamide analogs as Grp94 inhibitors.

Authors:  Aaron Muth; Vincent Crowley; Anuj Khandelwal; Sanket Mishra; Jinbo Zhao; Jessica Hall; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2014-06-12       Impact factor: 3.641

Review 4.  Heat shock protein 90: its inhibition and function.

Authors:  Abbey D Zuehlke; Michael A Moses; Len Neckers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

5.  A Scaffold Merging Approach to Hsp90 C-terminal Inhibition: Synthesis and Evaluation of a Chimeric Library.

Authors:  Rachel E Davis; Zheng Zhang; Brian S J Blagg
Journal:  Medchemcomm       Date:  2017-01-17       Impact factor: 3.597

Review 6.  Perspectives on the recent developments with green tea polyphenols in drug discovery.

Authors:  Feng Li; Yongli Wang; Dapeng Li; Yilun Chen; Xuguang Qiao; Rania Fardous; Ashton Lewandowski; Jinbao Liu; Tak-Hang Chan; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2018-04-24       Impact factor: 6.098

Review 7.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 8.  Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?

Authors:  Anuj Khandelwal; Vincent M Crowley; Brian S J Blagg
Journal:  Med Res Rev       Date:  2015-05-25       Impact factor: 12.944

9.  Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.

Authors:  Bhaskar Reddy Kusuma; Anuj Khandelwal; Wen Gu; Douglas Brown; Weiya Liu; George Vielhauer; Jeffrey Holzbeierlein; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2014-01-03       Impact factor: 3.641

10.  Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.

Authors:  Katherine M Byrd; Chitra Subramanian; Jacqueline Sanchez; Hashim F Motiwala; Weiya Liu; Mark S Cohen; Jeffrey Holzbeierlein; Brian S J Blagg
Journal:  Chemistry       Date:  2016-04-01       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.